Keywords: Eli Lilly, Kyowa, Livalo, Statin, Licensing, USA, Latin America

Lilly in deal with Kowa to co-promote newly-approved statin Livalo in USA and commercialization rights for Latin America

Article | 24 December 2009

Print This

US drug major Eli Lilly has signed an accord with Kowa Pharmaceuticals America, the US subsidiary of Japan’s Kyowa, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in